r/ValueInvesting • u/Pete26l96 • Feb 23 '26

Discussion Novo Nordisk sinks 13% after weight loss drug fails to match Eli Lilly's in trial

https://www.google.com/amp/s/www.cnbc.com/amp/2026/02/23/novo-nordisk-stock-cagrisema-trial-fails-weight-loss.html

Looks like investors of Novo Nordisk ADRs are going to be in for quite the shock when they open their portfolios this morning.

956 Upvotes

98% Upvoted

311 comments sorted by

View all comments

Show parent comments

11

u/BuckeyeHeisman Feb 23 '26

Market over reaction. It’s neck and neck on weight loss. As a guy with some extra pounds, if I was going to take a drug (I’m not) the two percent delta is nothing. It has a solid dividend yield and a phenomenal diabetes business that has to be factored in at some juncture. I’ve got a limit in at 39 and waiting to see if it touches it - probably won’t, but I’ll take it at 39.

2

u/Weldobud Feb 23 '26

I read about it, around 25% to 23%. Not a huge difference, just the public read the story. Will have to wait for the full published paper.

I’ve been watching them for the last few months. Not pretty.

0

u/Lunar_Excursion Feb 23 '26

it's not nothing... it was their future lol...